← Back to Search

RCBI Program for TBI Recidivism Reduction (RCBI Trial)

N/A

Recruiting

Led By Devan Parrott, PhD

Research Sponsored by Rehabilitation Hospital of Indiana

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ages 18 and older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 2 weeks, 3 months

Awards & highlights

RCBI Trial Summary

This trial aims to reduce recidivism and violent offenses among individuals with TBI by implementing a Reentry Continuum for Brain Injury. 102 individuals with TBI will be randomly assigned to the intervention or a control group, and recidivism data will be collected over time.

Who is the study for?

This trial is for adults with a history of moderate to severe traumatic brain injury (TBI) who are currently serving sentences at PCF in Greencastle, Indiana and have 5 to 8 months left in their sentence. It's not for those in solitary confinement or unable to understand the study.Check my eligibility

What is being tested?

The trial tests if the Reentry Continuum for Brain Injury (RCBI) program can reduce re-incarceration and violent offenses among TBI patients post-release. Participants will be randomly assigned to RCBI or typical aftercare and tracked for three years.See study design

What are the potential side effects?

Since this intervention involves social support services rather than medication, traditional side effects aren't expected. However, participants may experience varying psychological impacts from involvement in the program.

RCBI Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

RCBI Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 2 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 2 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Attributions of Intent Hostility Questionnaire (AIHQ)

Change in Behavioral Infractions

Change in Brain Injury Coping Skills Questionnaire (BICS-Q)

+6 more

Secondary outcome measures

Change in Behavioral Rating Inventory of Executive Function-Adult Version (BRIEF-A)

Level of Service Inventory - Revised (LSI-R)

RCBI Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: RCBIExperimental Treatment1 Intervention

Receiving RCBI intervention, including BICS, ICAN, and RF.

Group II: Treatment as usual- Control groupActive Control1 Intervention

Not receiving the RCBI intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Rehabilitation Hospital of IndianaLead Sponsor

12 Previous Clinical Trials

5,447 Total Patients Enrolled

Devan Parrott, PhDPrincipal Investigator - Indiana University

Rehabilitation Hospital of Indiana

Media Library

Reentry Continuum for Brain Injury (RCBI) Clinical Trial Eligibility Overview. Trial Name: NCT04386681 — N/A

Traumatic Brain Injury Research Study Groups: RCBI, Treatment as usual- Control group

Traumatic Brain Injury Clinical Trial 2023: Reentry Continuum for Brain Injury (RCBI) Highlights & Side Effects. Trial Name: NCT04386681 — N/A

Reentry Continuum for Brain Injury (RCBI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04386681 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies for participants in this trial?

"As per data hosted on clinicaltrials.gov, this research initiative is presently bringing in participants and was initially announced on March 1st 2021 with the most recent edits to the study taking place April 5th 2021."

Answered by AI

What is the current capacity of this research trial?

"Yes, the information available on clinicaltrials.gov suggests this trial is currently recruiting patients. The experiment was initially posted on March 1st 2021 and recently modified on April 5th 2021. It requires 102 people from a single site to be enrolled."

Answered by AI

Who else is applying?

What site did they apply to?

Putnamville Correctional Facility

What portion of applicants met pre-screening criteria?

Met criteria

How many prior treatments have patients received?

Why did patients apply to this trial?

USMC Purple Heart veteran,acurired 3 TBI's all within one month from 3 separate IED Blast to our Vehicle striking a pressure on two of em but command det in the third. Still have all my fingers in tiws though, got lucky. But on the mental side of everything complet opposite of a nightmare going on. Ihave really received treatment but it is service connected and covered by Veterans Affairs for upon my eas from the Marines I've carried a 90% Service Connected Disability rating. It's. It'd be nice to get back to life one day if at all possible.

PatientReceived 2+ prior treatments

Recent research and studies

clinicaltrials.govStudy

Re-entry Continuum for Brain Injury

Devan Parrott 2021. "Re-entry Continuum for Brain Injury". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04386681.

All > Brain Injury